Global anti-biofilm wound dressings market was valued at USD 606.57 Million in 2020. It is expected to grow at a compound annual rate (CAGR of 9.2%) between 2021 and 2028. Market growth is being driven by the worldwide rise in chronic diseases like cancer and diabetes. The rising prevalence of non-communicable disease is due to factors such as unhealthy lifestyles, increased alcohol consumption, smoking, and antimicrobial resistance. According to studies by B. Braun Melsungen AG, around 2.3% to 10.0% of diabetics suffer from foot ulcers. According to the American College of Physicians, the worldwide incidence of diabetic foot ulcers was 6.3% in 2017. The lifetime incidence of foot ulcers in diabetes patients ranges between 19.0% and 34.0%. Market growth is expected to be significantly boosted by this factor. Anti-biofilm wound dressings are highly recommended for chronic wounds.
Many countries have delayed elective surgery and other healthcare procedures due to the COVID-19 epidemic. Patients with chronic and acute wounds should be treated at home, or in outpatient clinics. Therefore, there is a greater demand for home-based wound care products like anti-biofilm dressings. The demand for home healthcare is growing among the elderly population, who are at greater risk of contracting the infection and can't visit any healthcare facilities. Many patients also use online counseling to address their health concerns.
The U.S. CDC reports that 6 out 10 adults suffer from a chronic condition and 4 out 10 are living with two or more chronic conditions. Chronic diseases are also the leading cause for disability and death, and contribute to the USD 3.5 trillion annually in healthcare costs. Due to the increasing prevalence of chronic conditions, there has been an increase in the number of surgeries. To prevent infection of the surgical site, wound dressings such as silver-based dressings are being increasingly used. Many surgical wounds following cancer surgery are large and deep. This creates exudate that needs to be managed regularly. Silver- and iodine-based wound treatments are anti-biofilm products that can be used to treat large wounds. This reduces the chance of infection. Market growth is expected to be driven by the increasing incidence of chronic diseases.
The market is expected to grow due to an increase in the incidence of trauma events and burns around the world. According to WHO (2018), India has approximately 1,000,000 people who suffer from severe and moderate burns each year. According to the NCBI, there was a rise in burn injuries in 2017 in countries like Australia, China, Australia and the Netherlands. According to the American Association for the Surgery of Trauma in 2017, 1.2 million people died worldwide. Road accidents are responsible for approximately 3,242 deaths each day. Most road accidents occur in low- and middle-income countries. Majorly, biomaterials and skin replacements are used to heal all types of burn wounds. The market is likely to experience significant growth due to the increasing number of accidents.
The risk of injury is rising as more people engage in recreational and sports activities. According to Stanford Children's Health in the United States, more than 3.5 million injuries are reported each year among children and teenagers. Around 21% of all injuries are traumatic head injuries. According to the Canadian Institute for Health Information (CIHI), around 17.655 people were admitted to hospital for sports-related injuries between 2016 and 2017. According to the American Physical Therapy Association's 2017 report, 8.6 million sports-related injuries are reported each year in the U.S. Market growth will be aided by an increase in injuries.
Acute wounds accounted for the largest portion of the market, with 55.0%. This is due to rising incidences of burns and trauma as well as the increase in the number of surgeries performed around the world. Acute wounds are skin injuries that occur unexpectedly. They include incisions and abrasions as well as burns, scratches and puncture wounds. The regular wound healing process determines that it heals at a normal pace. These wounds can occur anywhere on the body, and range from minor scratches to large open wounds. Acute wounds can be further divided into surgical, traumatic and burns wounds. The severity and location of an acute wound will determine how it is treated. The primary treatment is to treat the wound and prevent biofilm from forming. Market growth is expected to be boosted by the rising number of acute wound patients.
Due to rising cases of diabetes and other chronic diseases around the world, the segment chronic wounds is expected to see the most rapid growth. Non-healing or chronic wounds are those that have not seen significant healing for more than four weeks. These wounds can become more severe and take longer to heal than expected. Chronic wounds can cause pain and infection, as well as increased infection. Chronic wounds can result from increased infection and pain in the wound. A chronic wound can affect anywhere from 1% to 2% of the population at any given time.
According to the U.S., chronic wounds affect approximately 6.5 million people. Chronic wounds are expected to rise with age and put a financial burden on society. The healthcare system spends more than USD 25 million annually in the United States on wound-related problems. According to the American Diabetes Association (ADA), there are more than 9-12 million Americans with chronic ulcers. The main drivers of this segment are increasing numbers of chronic diseases, particularly diabetes, and a growing geriatric population around the world. Each of these common wounds has its own characteristics. There are many types of chronic wounds. This chronic wound segment can be further broken down into pressure ulcers and diabetic foot ulcers.
In 2020, the chemical mode of mechanism segment accounted for the largest market share at over 40.0%. It is expected to experience the fastest growth due to rising chronic wounds and increasing surgeries around the world. Chemical-based anti-biofilm dressings can be multi-faceted in their action against biofilm. This allows for a faster healing process and higher recovery rates for chronic wounds. They reduce biofilm burden in chronic and acute wounds, and also lower the risk of microorganism recontamination. Further, the chemical segment can be broken down into ionic, iodine and EDTA.
The main factor driving segment growth is the presence of many players that offer anti-biofilm wound dressings with iodine or ionic silver. Researchers are also working to bring new anti-biofilm dressings to the market. This will help with chronic and acute wounds. In June 2020, the National Biofilms Innovation Centre (UK) announced a grant in the amount of USD 28949.03 to fund research and development of new products related to the detection, management, and engineering of biofilms. These factors will have a positive impact on the market's growth during the forecast period.
North America was the dominant market, with a greater than 40% share in 2020. It is expected to continue its dominance over the forecast period. Market growth is expected to be driven by factors such as the rising incidence of sports injuries and road accidents, and the presence key players in the region. Market growth is expected to be fueled by the availability of high-quality healthcare infrastructure and favorable reimbursement policies.
Asia Pacific is expected to experience the fastest growth over the forecast period. This region is expected to see rapid market growth due to the presence of developing countries like India, China, Japan, and China. The growing demand for wound dressing products is also being driven by the developing medical tourism industry. According to the Directorate-General of Commercial Intelligence and Statistics of India's report on Export Health Services, India had 58.300 medical tourists in 2015-2016.
The forecast period predicts that Latin America will grow at a substantial rate. Latin America's market will be driven by the presence of emerging economies like Brazil and Mexico. Latin America's access to advanced medical treatment at a low cost makes it a popular destination for medical tourism. The governments of Latin American countries have been actively involved in the improvement of healthcare infrastructure. These factors will drive the market's growth over the forecast period.
To gain competitive advantage, companies are investing in research and development to create technologically advanced products. Imbed Biosciences, for example, raised USD 1.6 million in January 2018 to help it introduce Microlyte AG, a silver-based antibiofilm wound dressing product into the market. This was after its research.
In order to increase their product range, increase their manufacturing capabilities, and differentiate themselves from their competitors, companies are engaging in mergers, acquisitions, and partnerships. Smith & Nephew PLC, which specializes on regenerative medicine products, announced in April 2019 that it had acquired Osiris Therapeutics, Inc. This acquisition will allow the company to expand its market reach and customer base by accelerating the development of its advanced products for wound management. The company's growth is expected to be boosted by this initiative. The following are some of the major players in anti-biofilm wound dressings market:
ConvaTec
Smith & Nephew PLC
Urgo Medical
Coloplast
3M
Up Market Research published a new report titled “Anti-biofilm Wound Dressing Market research report which is segmented by Application (Acute Wounds, Chronic Wounds), by Mode of Mechanism (Chemical, Physical, Biological), By Players/Companies ConvaTec, 3M, Smith & Nephew PLC, Urgo Medical, Coloplast”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Anti-biofilm Wound Dressing Market Research Report |
By Application | Acute Wounds, Chronic Wounds |
By Mode of Mechanism | Chemical, Physical, Biological |
By Companies | ConvaTec, 3M, Smith & Nephew PLC, Urgo Medical, Coloplast |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 220 |
Number of Tables & Figures | 154 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Application (Acute Wounds, Chronic Wounds), by Mode of Mechanism (Chemical, Physical, Biological).
Anti-biofilm Wound Dressing Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Anti-biofilm Wound Dressing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Anti-biofilm Wound Dressing Market Report:
Some other reports from this category!